CIK 0001410098 · Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Dillione Janet Director | Option exercise · Stock Option (Right to Buy Common Stock) | −5,677 | 24,323 | ||
| 2025-11-14 | Dillione Janet Director | Sale | −30,000 | $11.42 | $343K | 48,473 |
| 2025-10-23 | Kaplan Myron Director | Purchase | +25,000 | $11.02 | $276K | 201,034 |
| 2025-09-16 | Duncan Gregory Scott Director | Option exercise | +13,333 | $8.32 | $111K | 38,333 |
| 2025-09-16 | Duncan Gregory Scott Director | Option exercise · Stock Option (Right to Buy Common Stock) | −13,333 | 6,667 | ||
| 2025-09-12 | DUNTON ALAN W Director | Option exercise | +10,000 | $3.55 | $36K | 50,250 |
| 2025-09-12 | DUNTON ALAN W Director | Sale | −10,000 | $13.13 | $131K | 40,250 |
| 2025-09-12 | DUNTON ALAN W Director | Option exercise · Stock Option (Right to Buy Common Stock) | −10,000 | 20,000 | ||
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Option exercise | +50,000 | $3.47 | $174K | 559,496 |
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Sale | −50,000 | $13.00 | $650K | 509,496 |
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Option exercise · Stock Option (Right to Buy Common Stock) | −50,000 | 216,667 | ||
| 2025-09-11 | Hurlburt Elizabeth Chief Operating Officer | Option exercise | +41,121 | $1.45 | $60K | 218,111 |
| 2025-09-11 | Hurlburt Elizabeth Chief Operating Officer | Sale | −41,121 | $13.08 | $538K | 176,990 |
| 2025-09-11 | Hurlburt Elizabeth Chief Operating Officer | Option exercise · Stock Option (Right to Buy Common Stock) | −41,121 | 0 | ||
| 2025-09-09 | Zelnick Kaufman Beth Chief Legal Officer | Option exercise | +50,000 | $3.30 | $165K | 230,418 |
| 2025-09-09 | Zelnick Kaufman Beth Chief Legal Officer | Sale | −49,600 | $13.41 | $665K | 180,818 |
| 2025-09-09 | Zelnick Kaufman Beth Chief Legal Officer | Sale | −400 | $12.82 | $5K | 180,418 |
| 2025-09-09 | Zelnick Kaufman Beth Chief Legal Officer | Option exercise · Stock Option (Right to Buy Common Stock) | −50,000 | 150,000 | ||
| 2025-09-09 | Hurlburt Elizabeth Chief Operating Officer | Option exercise | +12,876 | $1.45 | $19K | 189,866 |
| 2025-09-09 | Hurlburt Elizabeth Chief Operating Officer | Sale | −12,876 | $13.51 | $174K | 176,990 |
Page 4 of 9 · 176 trades